1. Integration of Molecular Docking and In Vitro Studies: A Powerful Approach for Drug Discovery in Breast Cancer
   Claudia Cava et al, 2020, Applied Sciences CrossRef
2. Design and synthesis of triazole-functionalized isatin hybrids with potent anti-proliferative action against triple-negative breast cancer MDA-MB-231 cell line: a hybrid pharmacophore approach
   Jyoti Rasgania et al, 2024, Journal of the Iranian Chemical Society CrossRef
3. Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)-s-triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades
   Ihab Shawish et al, 2022, ACS Omega CrossRef
4. Triazine Derivative as Putative Candidate for the Reduction of Hormone-Positive Breast Tumor: In Silico, Pharmacological, and Toxicological Approach
   Muhammad Tayyab Imtiaz et al, 2021, Frontiers in Pharmacology CrossRef
5. Recent Advances in the Biological Activity of s-Triazine Core Compounds
   Dawid Maliszewski et al, 2022, Pharmaceuticals CrossRef
6. 1,3,5 and 1,2,4-triazines as Potent Scaffolds for Molecules Potentially Attenuating Breast Cancer Cell Lines
   Pragya Dubey et al, 2023, Current Organic Chemistry CrossRef
7. Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors
   Ihab Shawish et al, 2022, Frontiers in Chemistry CrossRef
8. Aminoquinoline-triazine Conjugates: Design, Synthesis, Antibacterial Activity, and SAR Analysis
   Hans Raj Bhat et al, 2023, Letters in Drug Design & Discovery CrossRef
9. A concise review on anti-breast cancer effectiveness of s-triazines through EGFR kinase inhibition
   Pooja Tandel et al, 2024, Medicinal Chemistry Research CrossRef